MedTrace Logo

Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA)

NCT02571920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3099

Last updated 2017-11-30

No results posted yet for this study

Summary

Describe the proportion of patients who underwent cardiac surgery in France and benefiting from a monitoring cardiac output, describe the use of positive inotropic and vasoactive agents for cardiac surgery patients operated (type of catecholamines, their duration), describe the fluid replacement and transfusions of first 24 hours, describe the incidence of postoperative complications in patients undergoing cardiac surgery.

Conditions

  • C.Surgical Procedure; Cardiac

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Marc-Olivier Fischer · University Hospital, Caen

  • Fabien Dechanet · University Hospital, Caen

  • Raphaël D'Orlando · University Hospital, Caen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02571920 on ClinicalTrials.gov